Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become one of the most serious public health crises worldwide. Most infected people are asymptomatic but are still able to spread the virus. People with mild or moderate illnesses are likely to recover without hospitalization, while crit...

Full description

Bibliographic Details
Main Authors: Dat Nguyen Thanh, Nguyen Tan Thanh Giang, Tam Vy Le, Ngoc Minh Truong, Thanh Van Ngo, Thien Ngoc Lam, Dinh Truong Nguyen, Quynh Hoa Tran, Minh Nam Nguyen
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023011520
_version_ 1797851901651320832
author Dat Nguyen Thanh
Nguyen Tan Thanh Giang
Tam Vy Le
Ngoc Minh Truong
Thanh Van Ngo
Thien Ngoc Lam
Dinh Truong Nguyen
Quynh Hoa Tran
Minh Nam Nguyen
author_facet Dat Nguyen Thanh
Nguyen Tan Thanh Giang
Tam Vy Le
Ngoc Minh Truong
Thanh Van Ngo
Thien Ngoc Lam
Dinh Truong Nguyen
Quynh Hoa Tran
Minh Nam Nguyen
author_sort Dat Nguyen Thanh
collection DOAJ
description Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become one of the most serious public health crises worldwide. Most infected people are asymptomatic but are still able to spread the virus. People with mild or moderate illnesses are likely to recover without hospitalization, while critically ill patients face a higher risk of organ injury or even death. In this study, we aimed to identify a novel biomarker that can predict the severity of COVID-19 patients. Clinical information and RNA-seq data of leukocytes from whole blood samples with and without a COVID-19 diagnosis (n = 100 and 26, respectively) were retrieved from the National Center for Biotechnology Information Gene Expression Omnibus database. Raw data were processed using the Transcripts Per Million (TPM) method and then transformed using log2 (TPM+1) for normalization. The CD24-CSF1R index was established. Violin plots, Kaplan-Meier curves, ROC curves, and multivariate Cox proportional hazards regression analyses were performed to evaluate the prognostic value of the established index. The CD24-CSF1R index was significantly associated with ICU admission (n = 50 ICU, 50 non-ICU) and ventilatory status (n = 42 ventilation, 58 non-ventilation) with p = 4.186e-11 and p = 1.278e-07, respectively. The ROC curve produced a relatively accurate prediction of ICU admission with an AUC of 0.8524. Additionally, patients with a high index had significantly fewer mechanical ventilation-free days than patients with a low index (p = 6.07e−07). Furthermore, the established index showed a strong prognostic ability for the risk of using a ventilator in the multivariate Cox regression model (p < 0.001). The CD24-CSF1R index was significantly associated with COVID-19 severity. The established index could have potential implications for prognosis, disease severity stratification, and clinical management.
first_indexed 2024-04-09T19:24:14Z
format Article
id doaj.art-312db5788d094c6887fa4242078d0227
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-09T19:24:14Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-312db5788d094c6887fa4242078d02272023-04-05T08:19:46ZengElsevierHeliyon2405-84402023-03-0193e13945Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samplesDat Nguyen Thanh0Nguyen Tan Thanh Giang1Tam Vy Le2Ngoc Minh Truong3Thanh Van Ngo4Thien Ngoc Lam5Dinh Truong Nguyen6Quynh Hoa Tran7Minh Nam Nguyen8School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam; Research Center for Genetics and Reproductive Health, School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet NamSchool of Biotechnology, Tan Tao University, Duc Hoa, Tan Duc E.City, Long An, 850000, Viet NamSchool of Biotechnology, Tan Tao University, Duc Hoa, Tan Duc E.City, Long An, 850000, Viet NamDepartment of Biotechnology, International University - Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet NamSchool of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet NamSchool of Biotechnology, Tan Tao University, Duc Hoa, Tan Duc E.City, Long An, 850000, Viet NamDepartment of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, United StatesDepartment of Biology and Environment, Ho Chi Minh City University of Food Industry (HUFI), Ho Chi Minh City 700000, Viet NamSchool of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam; Research Center for Genetics and Reproductive Health, School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam; Department of Biomedical Engineering, School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam; Corresponding author. School of Medicine, Vietnam National University Ho Chi Minh City, Linh Trung ward, Thu Duc District, Ho Chi Minh City, Viet Nam.Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has become one of the most serious public health crises worldwide. Most infected people are asymptomatic but are still able to spread the virus. People with mild or moderate illnesses are likely to recover without hospitalization, while critically ill patients face a higher risk of organ injury or even death. In this study, we aimed to identify a novel biomarker that can predict the severity of COVID-19 patients. Clinical information and RNA-seq data of leukocytes from whole blood samples with and without a COVID-19 diagnosis (n = 100 and 26, respectively) were retrieved from the National Center for Biotechnology Information Gene Expression Omnibus database. Raw data were processed using the Transcripts Per Million (TPM) method and then transformed using log2 (TPM+1) for normalization. The CD24-CSF1R index was established. Violin plots, Kaplan-Meier curves, ROC curves, and multivariate Cox proportional hazards regression analyses were performed to evaluate the prognostic value of the established index. The CD24-CSF1R index was significantly associated with ICU admission (n = 50 ICU, 50 non-ICU) and ventilatory status (n = 42 ventilation, 58 non-ventilation) with p = 4.186e-11 and p = 1.278e-07, respectively. The ROC curve produced a relatively accurate prediction of ICU admission with an AUC of 0.8524. Additionally, patients with a high index had significantly fewer mechanical ventilation-free days than patients with a low index (p = 6.07e−07). Furthermore, the established index showed a strong prognostic ability for the risk of using a ventilator in the multivariate Cox regression model (p < 0.001). The CD24-CSF1R index was significantly associated with COVID-19 severity. The established index could have potential implications for prognosis, disease severity stratification, and clinical management.http://www.sciencedirect.com/science/article/pii/S2405844023011520SARS-CoV-2COVID-19BiomarkerCD24-CSF1R indexImmunity
spellingShingle Dat Nguyen Thanh
Nguyen Tan Thanh Giang
Tam Vy Le
Ngoc Minh Truong
Thanh Van Ngo
Thien Ngoc Lam
Dinh Truong Nguyen
Quynh Hoa Tran
Minh Nam Nguyen
Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
Heliyon
SARS-CoV-2
COVID-19
Biomarker
CD24-CSF1R index
Immunity
title Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
title_full Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
title_fullStr Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
title_full_unstemmed Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
title_short Predicting the severity of COVID-19 patients using the CD24-CSF1R index in whole blood samples
title_sort predicting the severity of covid 19 patients using the cd24 csf1r index in whole blood samples
topic SARS-CoV-2
COVID-19
Biomarker
CD24-CSF1R index
Immunity
url http://www.sciencedirect.com/science/article/pii/S2405844023011520
work_keys_str_mv AT datnguyenthanh predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT nguyentanthanhgiang predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT tamvyle predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT ngocminhtruong predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT thanhvanngo predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT thienngoclam predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT dinhtruongnguyen predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT quynhhoatran predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples
AT minhnamnguyen predictingtheseverityofcovid19patientsusingthecd24csf1rindexinwholebloodsamples